How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

UF scientists have developed a compound that safely activates delta opioid receptors, offering pain relief without ...

If benzos and barbies aren't available, then it's down to the muscle relaxants, anticonvulsants and blood-pressure medications.

The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...

System that prioritizes opioids over non-addictive alternatives needs fixing, says ophthalmologist and Kansas senator.

The opioid crisis has claimed the lives of over half a million Americans since the beginning of the epidemic, a process ...

Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

Opioid addiction remains a major public health crisis in the United States, with post-surgical prescriptions often playing a significant role.

Heading into 2025, an even bigger game changer for the company may be Journavx, approved in January by the FDA as the first oral non-opioid painkiller in its class. Journavx taps into a massive ...